Where will cholangiocarcinoma spread first?

summary

Cholangiocarcinoma is a malignant tumor originating from the extrahepatic bile duct, including the bile duct from the hilar region to the lower end of the common bile duct. Its etiology may be related to bile duct stones, primary sclerosing cholangitis and other diseases. Clinically, cholangiocarcinoma has the characteristics of high malignancy and poor prognosis, which seriously threatens people's life and health. Now I'll talk about where cholangiocarcinoma will spread first? Let me tell you this.

Where will cholangiocarcinoma spread first?

First: surgery is one of the common clinical treatment methods, which belongs to local treatment. For the free cancer cells in the body of patients, can not be effectively controlled, so do not have the conditions for surgical treatment. In addition, for older and frail patients with gallbladder cancer, surgery is not suitable for surgical treatment to a certain extent because of the greater trauma to the patient's body.

Second: clinically, radiotherapy and chemotherapy is also one of the important methods for the treatment of cancer. Radiotherapy and chemotherapy can effectively control cancer cells, quickly control the disease, and temporarily prolong the life of patients. However, due to the lack of certain selectivity of radiotherapy and chemotherapy, there are many adverse reactions such as nausea, vomiting, weight loss and so on, which can not achieve the ultimate treatment of both symptoms and signs. If overuse, it will damage the immune function of patients, but will accelerate the death of patients.

Third: surgery is one of the common clinical treatment methods, which belongs to local treatment. For the free cancer cells in the body of patients, can not be effectively controlled, so do not have the conditions for surgical treatment. In addition, for older and frail patients with gallbladder cancer, surgery is not suitable for surgical treatment to a certain extent because of the greater trauma to the patient's body.

matters needing attention

Due to the lack of certain selectivity in chemoradiotherapy, it has the disadvantages of no distinction between the enemy and ourselves, leading to many patients with nausea, vomiting, weight loss and other adverse reactions. If overuse, it will damage the immune function of patients, but will accelerate the death of patients.